Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: Preliminary results

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 291-297

  Toyoshima, Takeshi ^a,b   Vairaktaris, Eleftherios ^c   Nkenke, Emeka ^a   Schlegel, Karl Andreas ^a   Neukam, Friedrich Wilhelm ^a   Ries, Jutta ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cytokeratin; Disseminated tumor cells; Oral squamous cell carcinoma; Peripheral blood; SYBR green real time quantitative reverse transcriptase polymerase chain reaction

Indexed keywords

CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-20; LEUKOCYTES, MONONUCLEAR; MALE; MOUTH NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 61449182795     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mohr C: Report on the 27th Annual Meeting of the German-Austrian-Swiss Working Group for Tumors of the Maxillofacial Area. Mund Kiefer Gesichtschir 1: 125-126, 1997.
2. Lim YC and Choi EC: Surgery alone for squamous cell carcinoma of the oral cavity: survival rates, recurrence patterns, and salvage treatment. Acta Otolaryngol 7: 1-6, 2008.
3. Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R and Ang KK: Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 3: 281-288, 2008.
4. Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW and Sauer R: Five-year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study. Strahlenther Onkol 183: 184-189, 2007.
5. Garzino-Demo P, Dell' Acqua A, Dalmasso P, Fasolis M, La Terra Maggiore GM, Ramieri G, Berrone S, Rampino M and Schena M: Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma. J Craniomaxillofac Surg 34: 344-350, 2006.
6. Pantel K and Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456, 2004.
7. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B and Selby P: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71: 278-281, 1995.
8. Noguchi T, Shibata T, Fumoto S, Sato T, Uchida Y, Daa T, Yokoyama S, Gabbert HE, Mueller W and Takeno S: Detection of disseminated cancer cells in rib marrow of patients with esophageal cancer. Oncol Rep 10: 623-627, 2003.
9. Davelaar EM, van de Lande J, von Mensdorff-Pouilly S, Blankenstein MA, Verheijen RH and Kenemans P: A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer. Tumour Biol 29: 9-17, 2008.
10. Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB and Dirix LY: Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br J Cancer 13: 672-680, 2006.
11. Partridge M, Brakenhoff R, Phillips E, Ali K, Francis R, Hooper R, Lavery K, Brown A and Langdon J: Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res 1: 5287-5294, 2003.
12. Soeth E, Grigoleit U, Moellmann B, Röder C, Schniewind B, Kremer B, Kalthoff H and Vogel I: Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol 131: 669-676, 2005.
13. Iinuma H, Okinaga K, Egami H, Mimori K, Hayashi N, Nishida K, Adachi M, Mori M and Sasako M: Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 28: 297-306, 2006.
14. Gath HJ, Heissler E, Hell B, Bier J, Riethmüller G and Pantel K: Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int J Oral Maxillofac Surg 24: 351-355, 1995.
15. Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW and Ries J: Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma. J Cancer Res Clin Oncol 134: 515-521, 2007.
16. Cohen-Kerem R, Madah W, Sabo E, Rahat MA, Greenberg E and Elmalah I: Cytokeratin-17 as a potential marker for squamous cell carcinoma of the larynx. Ann Otol Rhinol Laryngol 113: 821-827, 2004.
17. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Köchli OR, Mross F, Dieterich H, Seitz R, Ross D, Botstein D and Brown P: Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 161: 1991-1996, 2002.
18. Ikeda K, Tate G, Suzuki T and Mitsuya T: Coordinate expression of cytokeratin 8 and Cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature. Gynecol Oncol 108: 598-602, 2008.
19. Fillies T, Werkmeister R, Packeisen J, Brandt B, Morin P, Weingart D, Joos U and Buerger H: Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer 6: 10, 2006.
20. Zhong LP, Chen WT, Zhang CP and Zhang ZY: Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104: 377-384, 2006.
21. Katsumata K, Sumi T, Mori Y, Hisada M, Tsuchida A, Aoki T: Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR. Int J Clin Oncol 11: 385-389, 2006.
22. Chausovsky G, Luchansky M, Figer A, Shapira J, Gottfried M, Novis B, Bogelman G, Zemer R, Zimlichman S and Klein A: Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung. Cancer 1: 2398-2405, 1999.
23. Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V and Mavroudis D: Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res 14: 2593-2600, 2008.
24. Lloyd JM, McIver CM, Stephenson SA, Hewett PJ, Rieger N, Hardingham JE: Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 12: 417-423, 2006.
25. Kawamata H, Uchida D, Nakashiro K, Hino S, Omotehara F, Yoshida H, Sato M: Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. Br J Cancer 80: 448-452, 1999.
26. Sobin LH and Wittekind CH: International Union Against Cancer (UICC). TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss, 1997.
27. World Health Organization: International Histological Classification of Tumors, 2nd ed. Berlin: Springer-Verlag, 1988.
28. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
29. Jung R, Krüger W, Hosch S, Holweg M, Kroger N, Gutensohn K, Wagener C, Neumaier M and Zander AR: Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 78: 1194-1198, 1998.
30. Smith B, Selby P, Southgate J, Pittman K, Bradley C and Blair GE: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 16: 1227-1229, 1991.
31. Gläser R, Rass K, Seiter S, Hauschild A, Christophers E and Tilgen W: Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 15: 2818-2825, 1997.
32. Pantel K, Cote RJ and Fodstad O: Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 7: 1113-1124, 1999.
33. Yeh KH, Chen YC, Yeh SH, Chen CP, Lin JT and Cheng AL: Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (CK 19)-possible clinical significance in advanced gastric cancer. Anticancer Res 18: 1283-1286, 1998.
34. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG and Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82: 2605-2610, 1993.
35. Elsheikh MN, Mahfouz ME and Elsheikh E: Level IIb lymph nodes metastasis in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: a molecular-based study. Laryngoscope 115: 1636-1640, 2005.
36. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, Nekarda H and Siewert JR: Prognostic significance of cytokeratin-20 reverse transcriptase-polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 15: 1049-1055, 2002.
37. Osaka H, Yashiro M, Sawada T, Katsuragi K and Hirakawa K: Is a lymph node detected by the dye-guided method a true sentinel node in gastric cancer? Clin Cancer Res 10: 6912-6918, 2004.